IThenaPharma Inc. reported unaudited earnings results for the nine months ended September 30, 2016. For the period, operating loss was $340,836 against $921,328 a year ago. Loss before provision for income taxes was $340,757 against $920,782 a year ago. Net loss was $341,557 against $921,582 a year ago. Net loss per share - basic and diluted was $0.10 against $0.33 a year ago. Net cash used in operating activities was $295,664 against $702,794 a year ago.